Literature DB >> 2880808

Pseudomonas aeruginosa adhesins for tracheobronchial mucin.

R Ramphal, C Guay, G B Pier.   

Abstract

Mucins of the tracheobronchial tree are preferential sites for adherence and colonization by Pseudomonas aeruginosa. They possess specific receptors for this organism that have amino sugars as their principal constituents. Since mucins probably reflect the receptors on the cellular surfaces, we hypothesized that the bacterial adhesins previously shown to mediate the binding of P. aeruginosa to cells would also mediate bacterial binding to mucins. We therefore tested the roles of the exopolysaccharide from mucoid strains of P. aeruginosa and pili from nonmucoid strains to see whether they are indeed the adhesins for mucins. Using a microtiter plate assay of adherence to mucins, we demonstrated that the mucoid exopolysaccharide bound to mucins and enhanced the adherence of mucoid strains to this substance. Antibodies raised against the exopolysaccharide from a single mucoid strain inhibited the adherence of all mucoid strains tested. Purified pili from nonmucoid strains inhibited the binding of nonmucoid strains but not of mucoid strains. Inhibition of adherence by antibody to pili was quite specific, antibody being able to inhibit only the binding of the homologous nonmucoid strain. These data support our previous observations with tracheal cells, confirming the similarity of the adhesins for respiratory tract cells and the mucins which cover them.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2880808      PMCID: PMC260380          DOI: 10.1128/iai.55.3.600-603.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium.

Authors:  R Ramphal; J C Sadoff; M Pyle; J D Silipigni
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

2.  Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

Authors:  R B Fick; G P Naegel; S U Squier; R E Wood; J B Gee; H Y Reynolds
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

3.  Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin.

Authors:  S Vishwanath; R Ramphal
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

4.  Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation.

Authors:  R Ramphal; P M Small; J W Shands; W Fischlschweiger; P A Small
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

5.  Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.

Authors:  G B Pier; W J Matthews; D D Eardley
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

6.  Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.

Authors:  R Ramphal; G B Pier
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

7.  Immunochemical examination of the Pseudomonas aeruginosa glycocalyx: a monoclonal antibody which recognizes L-guluronic acid residues of alginic acid.

Authors:  R T Irvin; H Ceri
Journal:  Can J Microbiol       Date:  1985-03       Impact factor: 2.419

8.  Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells.

Authors:  D E Woods; D C Straus; W G Johanson; V K Berry; J A Bass
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

9.  Evidence for mucins and sialic acid as receptors for Pseudomonas aeruginosa in the lower respiratory tract.

Authors:  R Ramphal; M Pyle
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

View more
  41 in total

Review 1.  Recognition of mucin components by Pseudomonas aeruginosa.

Authors:  R Ramphal; S K Arora
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 2.  The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect.

Authors:  R Ramphal
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 3.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

4.  Pathogens responsible for concurrent sinusitis and pneumonia in intensive care unit patients.

Authors:  F Bert; N Lambert-Zechovsky
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

5.  Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.

Authors:  R A Hatch; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 6.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 7.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

8.  Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa.

Authors:  M S Reddy
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Arylneuraminidase activity of Pseudomonas aeruginosa does not degrade natural substrates such as human respiratory mucins.

Authors:  A Scharfman; R Ramphal; C Neut; C Carnoy; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins.

Authors:  C Carnoy; A Scharfman; E Van Brussel; G Lamblin; R Ramphal; P Roussel
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.